Raymond James Financial’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.43M Buy
2,888,636
+809,887
+39% +$2.31M ﹤0.01% 2161
2025
Q4
$5.13M Buy
2,078,749
+319,177
+18% +$760K ﹤0.01% 2491
2025
Q3
$3.92M Buy
1,759,572
+151,921
+9% +$348K ﹤0.01% 2638
2025
Q2
$3.87M Sell
1,607,651
-473,187
-23% -$1.15M ﹤0.01% 2551
2025
Q1
$4.85M Buy
2,080,838
+176,683
+9% +$353K ﹤0.01% 2350
2024
Q4
$3.52M Buy
+1,904,155
New +$4.21M ﹤0.01% 2557

Other funds holding ABEV

Raymond James Financial's ABEV Position: Q1 2026 in Review

Raymond James Financial increased its Ambev (ABEV) stake by 39% in Q1 2026, buying an estimated $2.31M and bringing the position to 2,888,636 shares worth $8.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

Raymond James Financial first reported a position in ABEV in Q4 2024 and has held it in 6 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Raymond James Financial held 2,888,636 shares of Ambev worth $8.43M as of Q1 2026.
  • Raymond James Financial bought 809,887 Ambev shares in Q1 2026, an estimated $2.31M.
  • Ambev made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2161 holding.
  • Raymond James Financial first reported a position in Ambev in Q4 2024 and has held it in 6 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.